1. Home
  2. CARM vs LDWY Comparison

CARM vs LDWY Comparison

Compare CARM & LDWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CARM
  • LDWY
  • Stock Information
  • Founded
  • CARM 2016
  • LDWY 1990
  • Country
  • CARM United States
  • LDWY United States
  • Employees
  • CARM N/A
  • LDWY N/A
  • Industry
  • CARM Biotechnology: Pharmaceutical Preparations
  • LDWY Advertising
  • Sector
  • CARM Health Care
  • LDWY Consumer Discretionary
  • Exchange
  • CARM Nasdaq
  • LDWY Nasdaq
  • Market Cap
  • CARM 8.4M
  • LDWY 9.2M
  • IPO Year
  • CARM N/A
  • LDWY 1991
  • Fundamental
  • Price
  • CARM $0.42
  • LDWY $4.90
  • Analyst Decision
  • CARM Hold
  • LDWY
  • Analyst Count
  • CARM 5
  • LDWY 0
  • Target Price
  • CARM $0.90
  • LDWY N/A
  • AVG Volume (30 Days)
  • CARM 42.1M
  • LDWY 6.5K
  • Earning Date
  • CARM 08-07-2025
  • LDWY 08-18-2025
  • Dividend Yield
  • CARM N/A
  • LDWY N/A
  • EPS Growth
  • CARM N/A
  • LDWY N/A
  • EPS
  • CARM N/A
  • LDWY N/A
  • Revenue
  • CARM $19,964,000.00
  • LDWY $42,183,000.00
  • Revenue This Year
  • CARM N/A
  • LDWY N/A
  • Revenue Next Year
  • CARM N/A
  • LDWY N/A
  • P/E Ratio
  • CARM N/A
  • LDWY N/A
  • Revenue Growth
  • CARM 32.45
  • LDWY 425.12
  • 52 Week Low
  • CARM $0.14
  • LDWY $3.02
  • 52 Week High
  • CARM $1.90
  • LDWY $5.53
  • Technical
  • Relative Strength Index (RSI)
  • CARM 52.02
  • LDWY 50.82
  • Support Level
  • CARM $0.41
  • LDWY $4.85
  • Resistance Level
  • CARM $0.56
  • LDWY $5.12
  • Average True Range (ATR)
  • CARM 0.13
  • LDWY 0.16
  • MACD
  • CARM -0.01
  • LDWY -0.05
  • Stochastic Oscillator
  • CARM 20.33
  • LDWY 7.84

About CARM Carisma Therapeutics Inc.

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.

About LDWY Lendway Inc. (DE)

Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two industries: Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.

Share on Social Networks: